Abstract
The Authors report their experience in the treatment of eleven patients over 70 years old (range from 70 to 83, average age 74.8, 7 males and 4 females), with histologically proven diagnosis of glioblastoma multiforme. The GC golden standard treatment is still debated, particularly in elderly patients. All the patients underwent a first line treatment with chemotherapy (Temozolomide), followed by Whole Brain Radiotherapy (WBRT) and PCV schedule without Vincristine in case of progression of the disease. The median survival was 16.3 months, ranging from 13 to 22 months. According to our experience, elderly patients should undergo the same treatment of younger patients, provided they are in good health conditions.
| Original language | English |
|---|---|
| Pages (from-to) | 183-187 |
| Number of pages | 5 |
| Journal | Journal of Experimental and Clinical Cancer Research |
| Volume | 25 |
| Issue number | 2 |
| Publication status | Published - Jun 2006 |
Fingerprint
Keywords
- Elderly patients
- Gliomatosis cerebri
- Magnetic resonance imaging
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Gliomatosis cerebri treatment in 11 elderly patients. / Piccirilli, M.; Landi, A.; Salvati, M.
In: Journal of Experimental and Clinical Cancer Research, Vol. 25, No. 2, 06.2006, p. 183-187.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Gliomatosis cerebri treatment in 11 elderly patients
AU - Piccirilli, M.
AU - Landi, A.
AU - Salvati, M.
PY - 2006/6
Y1 - 2006/6
N2 - The Authors report their experience in the treatment of eleven patients over 70 years old (range from 70 to 83, average age 74.8, 7 males and 4 females), with histologically proven diagnosis of glioblastoma multiforme. The GC golden standard treatment is still debated, particularly in elderly patients. All the patients underwent a first line treatment with chemotherapy (Temozolomide), followed by Whole Brain Radiotherapy (WBRT) and PCV schedule without Vincristine in case of progression of the disease. The median survival was 16.3 months, ranging from 13 to 22 months. According to our experience, elderly patients should undergo the same treatment of younger patients, provided they are in good health conditions.
AB - The Authors report their experience in the treatment of eleven patients over 70 years old (range from 70 to 83, average age 74.8, 7 males and 4 females), with histologically proven diagnosis of glioblastoma multiforme. The GC golden standard treatment is still debated, particularly in elderly patients. All the patients underwent a first line treatment with chemotherapy (Temozolomide), followed by Whole Brain Radiotherapy (WBRT) and PCV schedule without Vincristine in case of progression of the disease. The median survival was 16.3 months, ranging from 13 to 22 months. According to our experience, elderly patients should undergo the same treatment of younger patients, provided they are in good health conditions.
KW - Elderly patients
KW - Gliomatosis cerebri
KW - Magnetic resonance imaging
UR - http://www.scopus.com/inward/record.url?scp=33746384078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746384078&partnerID=8YFLogxK
M3 - Article
C2 - 16918128
AN - SCOPUS:33746384078
VL - 25
SP - 183
EP - 187
JO - Journal of Experimental and Clinical Cancer Research
JF - Journal of Experimental and Clinical Cancer Research
SN - 0392-9078
IS - 2
ER -